Nalaganje...
Limitations to antiarrhythmic drug use in patients with atrial fibrillation
BACKGROUND: Of the antiarrhythmic agents currently marketed in Canada, 5 are commonly used to treat atrial fibrillation (AF). The impact of contraindications, warnings and precautions for the use of these drugs in patients with AF is not known. We evaluated the proportion of patients with AF for who...
Shranjeno v:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Canadian Medical Association
2004
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC517859/ https://ncbi.nlm.nih.gov/pubmed/15451836 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1503/cmaj.1031277 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|